Asylum Research Eliminates Half of Veeco's Nanotechnology Patent Claims, Cloud Remains Over the Rest

Asylum Research, a premier manufacturer of atomic force microscopes, announced that the federal court in Los Angeles dismissed two of the five Veeco Instruments Inc. patents from the infringement lawsuit commenced by Veeco in September 2003 and that the judge’s summary judgment order (http://www.AsylumResearch.com/sj.pdf) cast a large shadow over their remaining patents.  This action eliminates 6 of 13 patent claims that Veeco brought against Asylum while all Asylum claims against Veeco remain. The court’s ruling was issued in March of this year, but had remained under seal until recently when the court lifted the seal at Asylum’s request.  At the same time the court set a March 2008 date for trial on the remaining issues of the suit.

“The standards for ruling on summary judgment are incredibly high, yet the judge dismissed nearly half of Veeco’s claims,” said Dick Clark, co-founder and general counsel of Asylum Research. “We are eager to go to trial this March, as ordered by the court. We will prove we do not infringe the few remaining Veeco claims and that they do infringe the claims of our patent.  We will also prove, following the lead of the court’s ruling, that each of the remaining Veeco patents is invalid for improper inventorship, among other reasons.”

Co-founder and CEO of Asylum Research Jason Cleveland commented, “Four years ago Veeco chose to pursue litigation rather than innovation. Their obvious hope was to financially starve a young competitor. That strategy has backfired and they now find themselves with a damaged portfolio and facing a possible infringement ruling for using our technology – technology that enables much faster, lower noise AFMs that will be required for Veeco to be competitive in the future.  While we are obviously very happy with this victory, we look forward to finishing the job at trial.”

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Asylum Research - An Oxford Instruments Company. (2019, February 15). Asylum Research Eliminates Half of Veeco's Nanotechnology Patent Claims, Cloud Remains Over the Rest. AZoNano. Retrieved on February 28, 2024 from https://www.azonano.com/news.aspx?newsID=5430.

  • MLA

    Asylum Research - An Oxford Instruments Company. "Asylum Research Eliminates Half of Veeco's Nanotechnology Patent Claims, Cloud Remains Over the Rest". AZoNano. 28 February 2024. <https://www.azonano.com/news.aspx?newsID=5430>.

  • Chicago

    Asylum Research - An Oxford Instruments Company. "Asylum Research Eliminates Half of Veeco's Nanotechnology Patent Claims, Cloud Remains Over the Rest". AZoNano. https://www.azonano.com/news.aspx?newsID=5430. (accessed February 28, 2024).

  • Harvard

    Asylum Research - An Oxford Instruments Company. 2019. Asylum Research Eliminates Half of Veeco's Nanotechnology Patent Claims, Cloud Remains Over the Rest. AZoNano, viewed 28 February 2024, https://www.azonano.com/news.aspx?newsID=5430.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit
Azthena logo

AZoM.com powered by Azthena AI

Your AI Assistant finding answers from trusted AZoM content

Your AI Powered Scientific Assistant

Hi, I'm Azthena, you can trust me to find commercial scientific answers from AZoNetwork.com.

A few things you need to know before we start. Please read and accept to continue.

  • Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
  • Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
  • Large Language Models can make mistakes. Consider checking important information.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.